FMP
NovoCure Limited
NVCR
NASDAQ
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
31.9 USD
0.93 (2.92%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Asaf Danziger
sector
Healthcare
industry
Medical - Instruments & Supplies
website
https://www.novocure.comexchange
NASDAQ
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, ...
CIK
0001645113
ISIN
JE00BYSS4X48
CUSIP
G6674U108
Address
No. 4 The Forum
Phone
44 15 3475 6700
Country
JE
Employee
1,453
IPO Date
Oct 1, 2015
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
NVCR Financial Summary
CIK
0001645113
Exchange
NASDAQ
Industry
Medical - Instrument...
Sector
Healthcare
CUSIP
G6674U108
ISIN
JE00BYSS4X48
Country
JE
Price
31.9
Beta
0.7
Volume Avg.
1.34M
Market Cap
3.45B
Shares
-
52-Week
11.7-34.13
DCF
0.69
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-22.95
P/B
-
Website
https://www.novocure.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest NVCR News
It looks like there's no news available.
